ABCN.V - ABcann Global Corporation

TSXV - TSXV Delayed Price. Currency in CAD
1.42
-0.10 (-6.58%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.52
Open1.50
Bid1.42 x 0
Ask1.43 x 0
Day's Range1.42 - 1.52
52 Week Range0.80 - 4.06
Volume800,886
Avg. Volume943,643
Market Cap276.139M
Beta0.01
PE Ratio (TTM)N/A
EPS (TTM)-0.27
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.55
  • GlobeNewswire3 days ago

    Harvest Medicine Surpasses 15,000 Patient Milestone in under 18 Months of Operation

    ABcann Global Corporation (ABCN.V) (“ABcann”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMed”), one of Canada’s fastest growing specialty medical cannabis clinics, has surpassed 15,000 active patients, reaching this significant milestone in under 18 months of operation. “Our rapid growth is a testament to our patient-centric approach and dedication to providing exceptional care,” stated Shekhar Parmar, Chief Executive Officer of HMed.

  • GlobeNewswire15 days ago

    ABcann Global Announces Results of Annual General Meeting

    ABcann Global Corporation (ABCN.V) (“ABcann” or the “Company”) is pleased to announce the results of its annual general and special meeting of shareholders held on June 5, 2018 (the “Meeting”). A total of 46,801,699 of the 191,001,305 common shares of the Company that were outstanding as at the record date were voted at the Meeting, representing 24.5% of such shares.

  • GlobeNewswirelast month

    ABcann Launches Beacon Medical

    ABcann Global Corporation (ABCN.V) (“ABcann” or the “Company”) is pleased to announce the launch of Beacon Medical, its new medical cannabis brand. “Our vision is to leverage our unique experience in the global pharmaceutical industry to create one of the most respected medical cannabis companies. The launch of Beacon is an important step towards that vision,” stated Barry Fishman, Chief Executive Officer.

  • ACCESSWIRElast month

    Today’s Research Reports on ABcann Global, Emerald Health Therapeutics, ESSA Pharma and Sernova

    NEW YORK, NY / ACCESSWIRE / May 15, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...

  • GlobeNewswire2 months ago

    ABcann Provides Business Update

    NAPANEE, Ontario, May 03, 2018-- ABcann Global Corporation is pleased to provide the following business update.. “Over the past two quarters, we have enhanced our leadership team, strengthened our balance ...

  • ACCESSWIRE2 months ago

    Today’s Research Reports on Canopy Growth, Spectral Medical, 3D Signatures and ABcann Global

    NEW YORK, NY / ACCESSWIRE / April 16, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • ACCESSWIRE3 months ago

    Today’s Research Reports on Emblem, 3D Signatures, ABcann Global and Theralase Technologies Inc.

    NEW YORK, NY / ACCESSWIRE / March 19, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group3 months ago

    Choom™ and ABcann Announce Strategic Investment and Supply Agreement

    OTCQB: CHOOF) (the "Company" or "Choom") and ABcann Global Corporation ("ABcann") (TSXV: ABCN, OTCQB: ABCCF) are pleased to announce that the Company has completed a financing of subscription receipts (each, a "Subscription Receipt") for gross proceeds of $7.0 million including a $4.0 million lead order from ABcann. Further to Choom's news release of March 19, 2018, the Company announces that it has completed a strategic private placement of Subscription Receipts concurrent with the execution of a definitive agreement relating to the acquisition of International Tungsten Inc. ("ITI").

  • CNW Group5 months ago

    IIROC Trading Resumption - ABCN

    VANCOUVER , Feb. 5, 2018 /CNW/ - Trading resumes in: Company: Abcann Global Corporation TSX-Venture Symbol: ABCN Resumption (ET): 10:01:21.886 AM IIROC can make a decision to impose a temporary suspension ...

  • PR Newswire5 months ago

    IIROC Trading Resumption - ABCN

    VANCOUVER , Feb. 5, 2018 /CNW/ - Trading resumes in: Company: Abcann Global Corporation TSX-Venture Symbol: ABCN Resumption (ET): 10:01:21.886 AM IIROC can make a decision to impose a temporary suspension ...

  • Newsfile5 months ago

    IIROC Trade Halt - ABcann Global Corporation

    Vancouver, British Columbia--(Newsfile Corp. - February 5, 2018) - The following issues have been halted by IIROC: Company:  ABcann Global Corporation TSX-V Symbol: ABCN ...

  • Newsfile5 months ago

    IIROC Trade Resumption - ABcann Global Corporation

    Vancouver, British Columbia--(Newsfile Corp. - February 5, 2018) - Trading resumes in: Company: ABcann Global Corporation TSX-V Symbol: ABCN ...

  • CNW Group5 months ago

    IIROC Trading Halt - ABCN

    VANCOUVER , Feb. 5, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Abcann Global Corporation TSX-Venture Symbol: ABCN Reason: Single Stock Circuit Breaker Halt Time (ET): 09:56:21.886 ...

  • PR Newswire5 months ago

    IIROC Trading Halt - ABCN

    VANCOUVER , Feb. 5, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Abcann Global Corporation TSX-Venture Symbol: ABCN Reason: Single Stock Circuit Breaker Halt Time (ET): 09:56:21.886 ...

  • Baystreet5 months ago

    Stocks in play: Abcann Global Corporation

    Has completed the acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement ...

  • CNW Group5 months ago

    ABcann Global Corporation Announces $70 Million Bought Deal Financing

    /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ./ NAPANEE, ON , Jan. 29, 2018 ...